These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9542694)

  • 1. An overview of three decades of research in pediatric psychopharmacoepidemiology.
    Gadow KD
    J Child Adolesc Psychopharmacol; 1997; 7(4):219-36. PubMed ID: 9542694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacoepidemiology of mental retardation: 1966 to 1995.
    Singh NN; Ellis CR; Wechsler H
    J Child Adolesc Psychopharmacol; 1997; 7(4):255-66. PubMed ID: 9542696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part I.
    Campbell M; Cueva JE
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1124-32. PubMed ID: 7559305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavior-disordered and aggressive children: new advances in pharmacotherapy.
    Campbell M; Anderson LT; Green WH
    J Dev Behav Pediatr; 1983 Dec; 4(4):265-71. PubMed ID: 6582068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
    Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacology research for individuals with mental retardation: methodological issues and suggestions.
    Matson JL; Bielecki J; Mayville SB; Matson ML
    Res Dev Disabil; 2003; 24(3):149-57. PubMed ID: 12742384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacology in autism.
    Tsai LY
    Psychosom Med; 1999; 61(5):651-65. PubMed ID: 10511014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting of medication regimen in applied studies of persons with mental retardation and ADHD.
    Christian L; Kerr CL; Sutphin GE; Poling A
    Res Dev Disabil; 1997; 18(5):319-27. PubMed ID: 9292927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
    Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
    Radigan M; Lannon P; Roohan P; Gesten F
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical issues in child and adolescent psychopharmacology.
    Gadow KD
    J Consult Clin Psychol; 1991 Dec; 59(6):842-52. PubMed ID: 1774369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychopharmacology of autistic disorders].
    Poustka L; Poustka F
    Z Kinder Jugendpsychiatr Psychother; 2007 Mar; 35(2):87-94. PubMed ID: 17608278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacotherapy in children and adults with intellectual disability.
    Santosh PJ; Baird G
    Lancet; 1999 Jul; 354(9174):233-42. PubMed ID: 10421318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Valicenti-McDermott MR; Demb H
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in pediatric psychopharmacology.
    Gualtieri CT; Golden RN; Fahs JJ
    J Dev Behav Pediatr; 1983 Sep; 4(3):202-9. PubMed ID: 6355189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment.
    Connor DF; Ozbayrak KR; Harrison RJ; Melloni RH
    J Child Adolesc Psychopharmacol; 1998; 8(1):27-38. PubMed ID: 9639077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.